430 related articles for article (PubMed ID: 27532768)
1. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
[TBL] [Abstract][Full Text] [Related]
2. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
[TBL] [Abstract][Full Text] [Related]
3. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
Smith D; Španěl P
J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
[TBL] [Abstract][Full Text] [Related]
5. Breath concentration of acetic acid vapour is elevated in patients with cystic fibrosis.
Smith D; Sovová K; Dryahina K; Doušová T; Dřevínek P; Španěl P
J Breath Res; 2016 May; 10(2):021002. PubMed ID: 27184114
[TBL] [Abstract][Full Text] [Related]
6. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
Pabary R; Huang J; Kumar S; Alton EW; Bush A; Hanna GB; Davies JC
Eur Respir J; 2016 Mar; 47(3):994-7. PubMed ID: 26846826
[No Abstract] [Full Text] [Related]
7. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry.
Shestivska V; Nemec A; Dřevínek P; Sovová K; Dryahina K; Spaněl P
Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2459-67. PubMed ID: 21818806
[TBL] [Abstract][Full Text] [Related]
8. From molecules in space to molecules in breath.
Smith D
Paediatr Respir Rev; 2016 Jan; 17():50-2. PubMed ID: 26541224
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection.
Smith D; Spaněl P; Gilchrist FJ; Lenney W
J Breath Res; 2013 Dec; 7(4):044001. PubMed ID: 24287489
[TBL] [Abstract][Full Text] [Related]
10. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry.
Carroll W; Lenney W; Wang T; Spanel P; Alcock A; Smith D
Pediatr Pulmonol; 2005 May; 39(5):452-6. PubMed ID: 15765542
[TBL] [Abstract][Full Text] [Related]
11. Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.
Purcaro G; Rees CA; Melvin JA; Bomberger JM; Hill JE
J Breath Res; 2018 Jul; 12(4):046001. PubMed ID: 29735804
[TBL] [Abstract][Full Text] [Related]
12. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis.
Savelev SU; Perry JD; Bourke SJ; Jary H; Taylor R; Fisher AJ; Corris PA; Petrie M; De Soyza A
Lett Appl Microbiol; 2011 Jun; 52(6):610-3. PubMed ID: 21438899
[TBL] [Abstract][Full Text] [Related]
13. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis.
Licht JC; Seidl E; Slingers G; Waters V; de Vries R; Post M; Ratjen F; Grasemann H
J Cyst Fibros; 2023 Sep; 22(5):888-893. PubMed ID: 36849333
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of volatile metabolites released in vitro by bacteria of the genus Stenotrophomonas for identification of breath biomarkers of respiratory infection in cystic fibrosis.
Shestivska V; Dryahina K; Nunvář J; Sovová K; Elhottová D; Nemec A; Smith D; Španěl P
J Breath Res; 2015 Apr; 9(2):027104. PubMed ID: 25830686
[TBL] [Abstract][Full Text] [Related]
16. Pentane and other volatile organic compounds, including carboxylic acids, in the exhaled breath of patients with Crohn's disease and ulcerative colitis.
Dryahina K; Smith D; Bortlík M; Machková N; Lukáš M; Španěl P
J Breath Res; 2017 Nov; 12(1):016002. PubMed ID: 28781264
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath analysis using electronic nose in cystic fibrosis and primary ciliary dyskinesia patients with chronic pulmonary infections.
Joensen O; Paff T; Haarman EG; Skovgaard IM; Jensen PØ; Bjarnsholt T; Nielsen KG
PLoS One; 2014; 9(12):e115584. PubMed ID: 25542036
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.
Robroeks CM; van Berkel JJ; Dallinga JW; Jöbsis Q; Zimmermann LJ; Hendriks HJ; Wouters MF; van der Grinten CP; van de Kant KD; van Schooten FJ; Dompeling E
Pediatr Res; 2010 Jul; 68(1):75-80. PubMed ID: 20351658
[TBL] [Abstract][Full Text] [Related]
19. Can exhaled volatile organic compounds predict asthma exacerbations in children?
van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
[TBL] [Abstract][Full Text] [Related]
20. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry--HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease.
Dummer J; Storer M; Sturney S; Scott-Thomas A; Chambers S; Swanney M; Epton M
J Breath Res; 2013 Mar; 7(1):017105. PubMed ID: 23445778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
